The Argument for Psychedelics #shorts

Typical psychiatric drugs you're taking for life, right? And you're taking multiple compounds and they kind of blunt the symptoms, but they don't really solve the problem. Whereas these compounds seem to, like in one dose or two doses, seem to relieve anxiety, depression, PTSD, to deal with addiction. Iboga literally can overnight shut down the physiology of heroin withdrawal, which is just as a doctor, so it makes me wonder what's going on here. To me, we're in this moment, we're kind of seeing the failure of traditional psychiatry as we see the psychedelic renaissance. And I'd love you to sort of comment on how you see this rolling out because currently, currently, the problem with these therapies is that a lot of the research is you take a dose of psilocybin and it's like six hours or MDMA, it's four or six hours. So it's a whole day for one therapist with a patient, which isn't really practical and scalable. So the question is how do we.

Begin to bring this to people who really need it? Well, I think it is practical and scalable. We have eight hour MDMA sessions, actually, so that, and we have two therapists for one person. So you need to really look at the outcomes and then look at the cost to society that's being averted, and then that's going the story to insurance companies.